Objectives: 1. Discuss the difference between Europe and the US when it comes to the dermal filler market.
2. Review what is going on in the US, where things stand, and what we can hope for in the near to not too distant future.
Introduction: One major difference between Europe and the US when it comes to the dermal filler market, is that in Europe, there are many fillers and filler companies bringing a myriad of products to our colleagues, which allows them great variety when it comes to using them for wrinkle reduction or for volumization.
Results: This is in stark contrast to the US, where we have a limited number of dermal fillers, due to a more stringent approval process by the US FDA and by the higher costs of running the clinical trials needed to bring a filler to the market. Several new fillers have recently been or will be approved and several more are primed to begin US clinical trials looking for approval when those trials are complete.
Conclusion: This presentation will review what is going on in the US, where things stand, and what we can hope for in the near to not too distant future.
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Allergan, Galderma, Merz Aesthetic, Prollenium, Croma
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Allergan, Galderma, Merz Aesthetic, Prollenium, Croma
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No
Este trabajo es presentado gracias al apoyo de: Allergan, Galderma, Merz Aesthetic, Prollenium, Croma